Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mark Evans

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
European Urology|December 29, 2009
A comparison of the frequencies of medical therapies for overactive bladder in men and women: analysis of more than 7.2 million aging patientsBrian T Helfand, R Mark Evans, Kevin T McVary
Plos One|August 24, 2018
An early analysis of the cost-effectiveness of a diagnostic classifier for risk stratification of haematuria patients (DCRSHP) compared to flexible cystoscopy in the diagnosis of bladder cancerAndrew J Sutton, John V Lamont, R Mark Evans, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
European Urology|December 29, 2009
A comparison of the frequencies of medical therapies for overactive bladder in men and women: analysis of more than 7.2 million aging patientsBrian T Helfand, R Mark Evans, Kevin T McVary
Plos One|August 24, 2018
An early analysis of the cost-effectiveness of a diagnostic classifier for risk stratification of haematuria patients (DCRSHP) compared to flexible cystoscopy in the diagnosis of bladder cancerAndrew J Sutton, John V Lamont, R Mark Evans, et al.
Pageof 1